Verve Therapeutics sees cash runway through 2026
PremiumThe FlyVerve Therapeutics sees cash runway through 2026
5d ago
Verve Therapeutics, Inc. (VERV) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Verve Therapeutics, Inc. (VERV) Q3 Earnings Cheat Sheet
7d ago
Verve Therapeutics’ (VERV) Gene-Editing Therapies Could Be a Game Changer
Premium
Market News
Verve Therapeutics’ (VERV) Gene-Editing Therapies Could Be a Game Changer
2M ago
Verve Therapeutics appoints Nia Tatsis, Jodie Morrison to board
PremiumThe FlyVerve Therapeutics appoints Nia Tatsis, Jodie Morrison to board
4M ago
Verve Therapeutics Announces New Chief Scientific Officer
Premium
Company Announcements
Verve Therapeutics Announces New Chief Scientific Officer
5M ago
Verve Therapeutics CSO Andrew Bellinger steps down, Troy Lister to succeed
Premium
The Fly
Verve Therapeutics CSO Andrew Bellinger steps down, Troy Lister to succeed
5M ago
Verve Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe FlyVerve Therapeutics initiated with a Buy at H.C. Wainwright
7M ago
Verve Therapeutics price target lowered to $40 from $56 at Stifel
Premium
The Fly
Verve Therapeutics price target lowered to $40 from $56 at Stifel
7M ago
Citi sees limited readthrough for Beam Therapeutics from VERVE-101 trial pause
Premium
The Fly
Citi sees limited readthrough for Beam Therapeutics from VERVE-101 trial pause
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100